43 results
425
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
21 Jun 22
Business combination disclosure
8:00am
Initiatives New Technologies (including new transgenic animals) TECHNOLOGIES AND INNOVATION ARE INFORMED BY DISCOVERY RELATIONSHIPS WITH OUR PARTNERS
22
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
21 Jun 22
Regulation FD Disclosure
6:19am
Initiatives New Technologies (including new transgenic animals) TECHNOLOGIES AND INNOVATION ARE INFORMED BY DISCOVERY RELATIONSHIPS WITH OUR PARTNERS
22
425
EX-99.1
ywt87qeb es2qvlrd
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.3
evombauffu 62d3h3kie
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
dekzk7a543b
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.3
pb9kt3286pxmqmg
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
bxgut s8lslolx
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K
EX-99.1
wrc6p1b fdzxdufmsg8u
20 Oct 20
Results of Operations and Financial Condition
10:52am